South African scientists to discuss Pfizer vaccine study
South African scientists will meet on Thursday to discuss a laboratory study that suggests the dominant local coronavirus variant may reduce antibody protection from the Pfizer vaccine by two-thirds, the health ministry said. The study, published in the New England Journal of Medicine late on Wednesday, includes additional data to one released in a pre-print review published in late January. South Africa plans to start rolling out the Pfizer/BioNTech vaccine in the coming months, after on Wednesday launching its vaccination programme with Johnson & Johnson's shot in a research stud...